Our Research
Discover our recent findings, catch up with news, and review in-depth resources.
Blog | Videos
Unlocking the Power of Ultrasensitive Bioanalysis
🔬 How do you measure complex modality molecules at the lowest possible concentrations?
For modern therapies like antibody-drug conjugates (ADCs) and inhzlation drugs, precise bioanalysis at picogram levels is essential to ensure both efficacy and safety. At Resolian, we specialize in ultrasensitive assays that push the boundaries of detection.
Blog | Videos
Advancing Immunoassay Method Development and Automation at Resolian
Precision, efficiency, and scientific expertise are essential in today’s fast-moving bioanalytical landscape. At Resolian, we’ve taken a bold step forward—restructuring teams, refining method development processes, and strategically implementing automation to enhance service delivery.
Blog
De-risk Your Drug Development with Resolian’s Polymorph Screening Expertise
Polymorph screening is a process that identifies and characterizes the crystalline forms of a compound, and then selects the best form for development.
Assessing and controlling the crystalline form of your material plays a crucial role in all the stages of the product lifecycle.
Videos
UK Lab Tour
Explore our UK labs in these site tours.
The staff may have changed but the capabilities remain.
Blog
Foreign Particulate Matter Solutions for Vaccine Safety
Foreign particulate matter (FPM) in vaccines poses risks to product safety, patient health, and regulatory compliance. With stringent guidelines from agencies like the FDA and EMA, identifying and controlling contaminants is essential to maintaining trust and ensuring safety.
Videos
Oligonucleotide Therapeutics Podcast
Min Meng, Chief Operations Officer at Resolian. The interview focuses on the bioanalysis of oligonucleotide therapeutics, a rapidly evolving area in drug development. Min Meng, with 20+ years of experience in this field, provides valuable insights into the unique challenges and advantages of these therapies.
